NEO
Neogenomics Inc
Price:  
15.97 
USD
Volume:  
748,080.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NEO Relative Valuation

-239.1%
Upside

As of 2024-03-02, the Relative Valuation of Neogenomics Inc (NEO) is (22.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.97 USD, the upside of Neogenomics Inc based on Relative Valuation is -239.1%.

The range of the Relative Valuation is (23.03) - (21.80) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 33.4x - 35.4x 34.1x
Forward P/E multiples 29.6x - 31.6x 30.4x
Fair Price (23.03) - (21.80) (22.22)
Upside -244.2% - -236.5% -239.1%
15.97 USD
Stock Price
(22.22) USD
Fair Price

NEO Relative Valuation - Historical P/E Data

Date P/E
2024-03-01 -23.18
2024-02-29 -22.64
2024-02-28 -22.58
2024-02-27 -23.41
2024-02-26 -23.61
2024-02-23 -24.37
2024-02-22 -23.87
2024-02-21 -23.92
2024-02-20 -21.33
2024-02-16 -20.84
2024-02-15 -21.62
2024-02-14 -21.62
2024-02-13 -20.75
2024-02-12 -22.00
2024-02-09 -20.84
2024-02-08 -21.04
2024-02-07 -20.40
2024-02-06 -21.02
2024-02-05 -20.57
2024-02-02 -21.31
2024-02-01 -21.48
2024-01-31 -21.55
2024-01-30 -22.47
2024-01-29 -23.80
2024-01-26 -22.66
2024-01-25 -23.08
2024-01-24 -23.00
2024-01-23 -23.18
2024-01-22 -23.22
2024-01-19 -22.83
2024-01-18 -22.54
2024-01-17 -22.44
2024-01-16 -22.48
2024-01-12 -22.96
2024-01-11 -22.95
2024-01-10 -23.18
2024-01-09 -23.40
2024-01-08 -23.31
2024-01-05 -22.66
2024-01-04 -22.89
2024-01-03 -23.38
2024-01-02 -23.15
2023-12-29 -23.48
2023-12-28 -24.37
2023-12-27 -29.75
2023-12-26 -29.88
2023-12-22 -30.09
2023-12-21 -29.82
2023-12-20 -27.92
2023-12-19 -29.04